JP7541986B2 - 三次元マトリックスなしでのヒト多能性幹細胞由来人工組織構造体の生成 - Google Patents
三次元マトリックスなしでのヒト多能性幹細胞由来人工組織構造体の生成 Download PDFInfo
- Publication number
- JP7541986B2 JP7541986B2 JP2021546212A JP2021546212A JP7541986B2 JP 7541986 B2 JP7541986 B2 JP 7541986B2 JP 2021546212 A JP2021546212 A JP 2021546212A JP 2021546212 A JP2021546212 A JP 2021546212A JP 7541986 B2 JP7541986 B2 JP 7541986B2
- Authority
- JP
- Japan
- Prior art keywords
- medium
- mpa
- cells
- organoids
- differentiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000001778 pluripotent stem cell Anatomy 0.000 title claims description 55
- 239000011159 matrix material Substances 0.000 title claims description 24
- 239000002609 medium Substances 0.000 claims description 188
- 230000004069 differentiation Effects 0.000 claims description 149
- 210000004027 cell Anatomy 0.000 claims description 125
- 210000001519 tissue Anatomy 0.000 claims description 112
- 230000001537 neural effect Effects 0.000 claims description 97
- 229920000609 methyl cellulose Polymers 0.000 claims description 71
- 239000001923 methylcellulose Substances 0.000 claims description 71
- 235000010981 methylcellulose Nutrition 0.000 claims description 71
- 238000000034 method Methods 0.000 claims description 66
- 239000003795 chemical substances by application Substances 0.000 claims description 51
- 230000002708 enhancing effect Effects 0.000 claims description 47
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 42
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 42
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 42
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 42
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 42
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 42
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 42
- 238000012258 culturing Methods 0.000 claims description 31
- 239000003112 inhibitor Substances 0.000 claims description 26
- 210000005260 human cell Anatomy 0.000 claims description 24
- 241001465754 Metazoa Species 0.000 claims description 23
- 210000004102 animal cell Anatomy 0.000 claims description 23
- 102000013814 Wnt Human genes 0.000 claims description 21
- 108050003627 Wnt Proteins 0.000 claims description 21
- 239000007640 basal medium Substances 0.000 claims description 21
- 230000006698 induction Effects 0.000 claims description 20
- 239000012190 activator Substances 0.000 claims description 17
- 238000000338 in vitro Methods 0.000 claims description 15
- 230000019491 signal transduction Effects 0.000 claims description 15
- 108010059616 Activins Proteins 0.000 claims description 13
- 102000005606 Activins Human genes 0.000 claims description 13
- 239000000488 activin Substances 0.000 claims description 13
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 13
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 12
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 12
- 239000000725 suspension Substances 0.000 claims description 12
- 230000011664 signaling Effects 0.000 claims description 11
- 238000004114 suspension culture Methods 0.000 claims description 10
- 230000001939 inductive effect Effects 0.000 claims description 8
- 210000000944 nerve tissue Anatomy 0.000 claims 2
- 210000002220 organoid Anatomy 0.000 description 218
- 210000004556 brain Anatomy 0.000 description 62
- 230000002490 cerebral effect Effects 0.000 description 45
- 230000014509 gene expression Effects 0.000 description 37
- 239000003623 enhancer Substances 0.000 description 35
- 108010082117 matrigel Proteins 0.000 description 28
- 239000003550 marker Substances 0.000 description 20
- 102000007354 PAX6 Transcription Factor Human genes 0.000 description 18
- 101150081664 PAX6 gene Proteins 0.000 description 18
- 210000002569 neuron Anatomy 0.000 description 18
- 239000010410 layer Substances 0.000 description 17
- 239000000203 mixture Substances 0.000 description 16
- 230000035755 proliferation Effects 0.000 description 16
- 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 15
- 239000000679 carrageenan Substances 0.000 description 14
- 229920001525 carrageenan Polymers 0.000 description 14
- 229940113118 carrageenan Drugs 0.000 description 14
- 230000001054 cortical effect Effects 0.000 description 14
- 238000011161 development Methods 0.000 description 13
- 230000018109 developmental process Effects 0.000 description 13
- 210000000130 stem cell Anatomy 0.000 description 13
- 235000010418 carrageenan Nutrition 0.000 description 12
- 230000004766 neurogenesis Effects 0.000 description 12
- 239000006254 rheological additive Substances 0.000 description 12
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 12
- 229920003086 cellulose ether Polymers 0.000 description 10
- 150000002170 ethers Chemical class 0.000 description 10
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 10
- 239000000230 xanthan gum Substances 0.000 description 10
- 229920001285 xanthan gum Polymers 0.000 description 10
- 235000010493 xanthan gum Nutrition 0.000 description 10
- 229940082509 xanthan gum Drugs 0.000 description 10
- 239000006143 cell culture medium Substances 0.000 description 9
- 210000001671 embryonic stem cell Anatomy 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 8
- 210000005155 neural progenitor cell Anatomy 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 7
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 7
- 229940112869 bone morphogenetic protein Drugs 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000037361 pathway Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 102100030751 Eomesodermin homolog Human genes 0.000 description 6
- 102100036083 T-box brain protein 1 Human genes 0.000 description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
- 238000000684 flow cytometry Methods 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 5
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 5
- 238000012512 characterization method Methods 0.000 description 5
- 210000002744 extracellular matrix Anatomy 0.000 description 5
- -1 for example Substances 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 210000004379 membrane Anatomy 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 238000000386 microscopy Methods 0.000 description 5
- 230000000926 neurological effect Effects 0.000 description 5
- 230000008672 reprogramming Effects 0.000 description 5
- 230000002207 retinal effect Effects 0.000 description 5
- 101710142207 Eomesodermin homolog Proteins 0.000 description 4
- 101710087964 Forkhead box protein G1 Proteins 0.000 description 4
- FABQUVYDAXWUQP-UHFFFAOYSA-N N4-(1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)pyrimidine-2,4-diamine Chemical compound COC1=CC=CC(C=2N=C(N)N=C(NCC=3C=C4OCOC4=CC=3)C=2)=C1 FABQUVYDAXWUQP-UHFFFAOYSA-N 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 238000000339 bright-field microscopy Methods 0.000 description 4
- 210000003850 cellular structure Anatomy 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000003102 growth factor Substances 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 210000003124 radial glial cell Anatomy 0.000 description 4
- 239000011435 rock Substances 0.000 description 4
- 150000003384 small molecules Chemical class 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 230000002861 ventricular Effects 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 102000015735 Beta-catenin Human genes 0.000 description 3
- 108060000903 Beta-catenin Proteins 0.000 description 3
- 102000000905 Cadherin Human genes 0.000 description 3
- 108050007957 Cadherin Proteins 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010067306 Fibronectins Proteins 0.000 description 3
- 102000016359 Fibronectins Human genes 0.000 description 3
- 102000003693 Hedgehog Proteins Human genes 0.000 description 3
- 108090000031 Hedgehog Proteins Proteins 0.000 description 3
- 101001094700 Homo sapiens POU domain, class 5, transcription factor 1 Proteins 0.000 description 3
- 101000713275 Homo sapiens Solute carrier family 22 member 3 Proteins 0.000 description 3
- 101000595526 Homo sapiens T-box brain protein 1 Proteins 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
- 108050000637 N-cadherin Proteins 0.000 description 3
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 3
- 108020004459 Small interfering RNA Proteins 0.000 description 3
- 101710202936 T-box brain protein 1 Proteins 0.000 description 3
- 239000000556 agonist Substances 0.000 description 3
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000004624 confocal microscopy Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000010494 dissociation reaction Methods 0.000 description 3
- 230000005593 dissociations Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000003981 ectoderm Anatomy 0.000 description 3
- 210000001900 endoderm Anatomy 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 210000005003 heart tissue Anatomy 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000002826 magnetic-activated cell sorting Methods 0.000 description 3
- 210000003716 mesoderm Anatomy 0.000 description 3
- 210000003061 neural cell Anatomy 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 210000004129 prosencephalon Anatomy 0.000 description 3
- 230000008707 rearrangement Effects 0.000 description 3
- 210000005084 renal tissue Anatomy 0.000 description 3
- 229930002330 retinoic acid Natural products 0.000 description 3
- 229960003471 retinol Drugs 0.000 description 3
- 239000011607 retinol Substances 0.000 description 3
- 235000020944 retinol Nutrition 0.000 description 3
- 239000004055 small Interfering RNA Substances 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 229960001727 tretinoin Drugs 0.000 description 3
- 102100022983 B-cell lymphoma/leukemia 11B Human genes 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
- 102000005698 Frizzled receptors Human genes 0.000 description 2
- 108010045438 Frizzled receptors Proteins 0.000 description 2
- 102000002254 Glycogen Synthase Kinase 3 Human genes 0.000 description 2
- 108010014905 Glycogen Synthase Kinase 3 Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 101000903697 Homo sapiens B-cell lymphoma/leukemia 11B Proteins 0.000 description 2
- 101001064167 Homo sapiens Eomesodermin homolog Proteins 0.000 description 2
- 108010085895 Laminin Proteins 0.000 description 2
- 102100026459 POU domain, class 3, transcription factor 2 Human genes 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 108091078718 R-spondin family Proteins 0.000 description 2
- 102000041829 R-spondin family Human genes 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 102000004338 Transferrin Human genes 0.000 description 2
- 108090000901 Transferrin Proteins 0.000 description 2
- 239000012574 advanced DMEM Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000004641 brain development Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000033026 cell fate determination Effects 0.000 description 2
- 230000003436 cytoskeletal effect Effects 0.000 description 2
- 230000013020 embryo development Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 210000004498 neuroglial cell Anatomy 0.000 description 2
- 108010008217 nidogen Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 101150027852 pou3f2 gene Proteins 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- 238000013341 scale-up Methods 0.000 description 2
- 230000009131 signaling function Effects 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 239000012581 transferrin Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JCSGFHVFHSKIJH-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-4-(1-methyl-3-indolyl)pyrrole-2,5-dione Chemical compound C12=CC=CC=C2N(C)C=C1C(C(NC1=O)=O)=C1C1=CC=C(Cl)C=C1Cl JCSGFHVFHSKIJH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 1
- 101710112282 Adenomatous polyposis coli protein Proteins 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- AQGNHMOJWBZFQQ-UHFFFAOYSA-N CT 99021 Chemical compound CC1=CNC(C=2C(=NC(NCCNC=3N=CC(=CC=3)C#N)=NC=2)C=2C(=CC(Cl)=CC=2)Cl)=N1 AQGNHMOJWBZFQQ-UHFFFAOYSA-N 0.000 description 1
- 101100156752 Caenorhabditis elegans cwn-1 gene Proteins 0.000 description 1
- 101100264044 Caenorhabditis elegans cwn-2 gene Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 108010059480 Chondroitin Sulfate Proteoglycans Proteins 0.000 description 1
- 102000005598 Chondroitin Sulfate Proteoglycans Human genes 0.000 description 1
- 108010042086 Collagen Type IV Proteins 0.000 description 1
- 102000004266 Collagen Type IV Human genes 0.000 description 1
- 241000766026 Coregonus nasus Species 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 101100317380 Danio rerio wnt4a gene Proteins 0.000 description 1
- 101100428956 Danio rerio wnt8b gene Proteins 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 102000017944 Dishevelled Human genes 0.000 description 1
- 108050007016 Dishevelled Proteins 0.000 description 1
- 101100373143 Drosophila melanogaster Wnt5 gene Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- KBEBGUQPQBELIU-CMDGGOBGSA-N Ethyl cinnamate Chemical compound CCOC(=O)\C=C\C1=CC=CC=C1 KBEBGUQPQBELIU-CMDGGOBGSA-N 0.000 description 1
- 241000132179 Eurotium medium Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101001139134 Homo sapiens Krueppel-like factor 4 Proteins 0.000 description 1
- 101000621344 Homo sapiens Protein Wnt-2 Proteins 0.000 description 1
- 101000855004 Homo sapiens Protein Wnt-7a Proteins 0.000 description 1
- 101000984042 Homo sapiens Protein lin-28 homolog A Proteins 0.000 description 1
- 101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 description 1
- 102100020677 Krueppel-like factor 4 Human genes 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 101000621352 Mus musculus Protein Wnt-2 Proteins 0.000 description 1
- 101100485095 Mus musculus Wnt10b gene Proteins 0.000 description 1
- 101100317378 Mus musculus Wnt3 gene Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 102100037369 Nidogen-1 Human genes 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 101150092239 OTX2 gene Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010050808 Procollagen Proteins 0.000 description 1
- 102100022805 Protein Wnt-2 Human genes 0.000 description 1
- 102100020729 Protein Wnt-7a Human genes 0.000 description 1
- 102100025460 Protein lin-28 homolog A Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- 102100022762 R-spondin-1 Human genes 0.000 description 1
- 101710110302 R-spondin-1 Proteins 0.000 description 1
- 102100022763 R-spondin-2 Human genes 0.000 description 1
- 101710110295 R-spondin-2 Proteins 0.000 description 1
- 102100022766 R-spondin-3 Human genes 0.000 description 1
- 101710110310 R-spondin-3 Proteins 0.000 description 1
- 102100022759 R-spondin-4 Human genes 0.000 description 1
- 101710110307 R-spondin-4 Proteins 0.000 description 1
- 239000012979 RPMI medium Substances 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- PQCXVIPXISBFPN-UHFFFAOYSA-N SB 415286 Chemical compound C1=C(Cl)C(O)=CC=C1NC1=C(C=2C(=CC=CC=2)[N+]([O-])=O)C(=O)NC1=O PQCXVIPXISBFPN-UHFFFAOYSA-N 0.000 description 1
- 101000767160 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Intracellular protein transport protein USO1 Proteins 0.000 description 1
- 108091084789 TCF/LEF family Proteins 0.000 description 1
- 102000043043 TCF/LEF family Human genes 0.000 description 1
- 108010008125 Tenascin Proteins 0.000 description 1
- 102000007000 Tenascin Human genes 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102100024270 Transcription factor SOX-2 Human genes 0.000 description 1
- 101150010310 WNT-4 gene Proteins 0.000 description 1
- 101150109862 WNT-5A gene Proteins 0.000 description 1
- 101150019524 WNT2 gene Proteins 0.000 description 1
- 230000004156 Wnt signaling pathway Effects 0.000 description 1
- 102000052547 Wnt-1 Human genes 0.000 description 1
- 108700020987 Wnt-1 Proteins 0.000 description 1
- 108700020986 Wnt-2 Proteins 0.000 description 1
- 102000052556 Wnt-2 Human genes 0.000 description 1
- 102000052549 Wnt-3 Human genes 0.000 description 1
- 108700020985 Wnt-3 Proteins 0.000 description 1
- 102000052548 Wnt-4 Human genes 0.000 description 1
- 108700020984 Wnt-4 Proteins 0.000 description 1
- 102000043366 Wnt-5a Human genes 0.000 description 1
- 108700020483 Wnt-5a Proteins 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- 101000770767 Xenopus laevis Protein Wnt-2b-A Proteins 0.000 description 1
- 101100485097 Xenopus laevis wnt11b gene Proteins 0.000 description 1
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 108010023082 activin A Proteins 0.000 description 1
- 238000004115 adherent culture Methods 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000002459 blastocyst Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- KBEBGUQPQBELIU-UHFFFAOYSA-N cinnamic acid ethyl ester Natural products CCOC(=O)C=CC1=CC=CC=C1 KBEBGUQPQBELIU-UHFFFAOYSA-N 0.000 description 1
- 230000004186 co-expression Effects 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 210000001608 connective tissue cell Anatomy 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 210000005257 cortical tissue Anatomy 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 210000002242 embryoid body Anatomy 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000005153 frontal cortex Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000002518 glial effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000001153 interneuron Anatomy 0.000 description 1
- QQUXFYAWXPMDOE-UHFFFAOYSA-N kenpaullone Chemical compound C1C(=O)NC2=CC=CC=C2C2=C1C1=CC(Br)=CC=C1N2 QQUXFYAWXPMDOE-UHFFFAOYSA-N 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000007762 localization of cell Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 210000001259 mesencephalon Anatomy 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000004264 monolayer culture Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000000651 myofibroblast Anatomy 0.000 description 1
- DOBKQCZBPPCLEG-UHFFFAOYSA-N n-benzyl-2-(pyrimidin-4-ylamino)-1,3-thiazole-4-carboxamide Chemical compound C=1SC(NC=2N=CN=CC=2)=NC=1C(=O)NCC1=CC=CC=C1 DOBKQCZBPPCLEG-UHFFFAOYSA-N 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000007472 neurodevelopment Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 239000000816 peptidomimetic Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 210000001202 rhombencephalon Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229940082569 selenite Drugs 0.000 description 1
- MCAHWIHFGHIESP-UHFFFAOYSA-L selenite(2-) Chemical compound [O-][Se]([O-])=O MCAHWIHFGHIESP-UHFFFAOYSA-L 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 108091005475 signaling receptors Proteins 0.000 description 1
- 102000035025 signaling receptors Human genes 0.000 description 1
- 235000021309 simple sugar Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2513/00—3D culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
- C12N2533/78—Cellulose
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19156450.9 | 2019-02-11 | ||
| EP19156450 | 2019-02-11 | ||
| PCT/EP2020/053237 WO2020165059A1 (en) | 2019-02-11 | 2020-02-10 | Generation of human pluripotent stem cell derived artificial tissue structures without three dimensional matrices |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022519376A JP2022519376A (ja) | 2022-03-23 |
| JP2022519376A5 JP2022519376A5 (https=) | 2023-02-13 |
| JP7541986B2 true JP7541986B2 (ja) | 2024-08-29 |
Family
ID=65408960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021546212A Active JP7541986B2 (ja) | 2019-02-11 | 2020-02-10 | 三次元マトリックスなしでのヒト多能性幹細胞由来人工組織構造体の生成 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220145247A1 (https=) |
| EP (1) | EP3924468A1 (https=) |
| JP (1) | JP7541986B2 (https=) |
| CA (1) | CA3129656A1 (https=) |
| WO (1) | WO2020165059A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4206320A4 (en) * | 2020-08-21 | 2025-02-12 | JSR Corporation | METHOD FOR CULTIVATION OF HUMAN INDUCED PLURIPOTENT STEM CELLS, CULTURE OF HUMAN INDUCED PLURIPOTENT STEM CELLS AND METHOD FOR THE PRODUCTION OF CEREBRAL ORGANOIDS |
| CN112685978B (zh) * | 2021-03-11 | 2021-06-08 | 中国空气动力研究与发展中心计算空气动力研究所 | 一种适用于五次样条重构格式的自适应人工粘性控制方法 |
| JPWO2022265086A1 (https=) * | 2021-06-17 | 2022-12-22 | ||
| EP4544025A1 (en) * | 2022-06-21 | 2025-04-30 | Institut National de la Santé et de la Recherche Médicale | A method for producing a bioengineered mammal induced pluripotent stem cell-derived cardiac organoid |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004515236A (ja) | 2000-12-07 | 2004-05-27 | スリーエム イノベイティブ プロパティズ カンパニー | 自己拡散式微生物培養装置 |
| JP2016506244A (ja) | 2012-12-13 | 2016-03-03 | イーエムベーアー−インスティテュート フュール モレクラレ バイオテクロノジー ゲゼルシャフト ミットベシュレンクテル ハフツング | 三次元不均一分化組織培養 |
| JP2018506988A (ja) | 2015-03-03 | 2018-03-15 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 機能的ヒト組織の作製方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0779772A (ja) * | 1993-09-13 | 1995-03-28 | W R Grace & Co | 細胞培養液及びその培養液を用いたスフェロイドの製造方法 |
| MXPA04005010A (es) | 2001-11-26 | 2005-04-08 | Advanced Cell Tech Inc | METODO PARA HACER Y USAR NUCLEOS CELULARES SOMáTICOS METODOS PARA HACER Y USAR NUCLEOS CELULARES SOMáTICOS HUMANOS REPROGRAMADOS Y CELULAS DEL TALLO HUMANAS AUTOLOGAS E ISOGENICAS. |
| JPWO2009148170A1 (ja) | 2008-06-06 | 2011-11-04 | 独立行政法人理化学研究所 | 幹細胞の培養方法 |
| JP5787370B2 (ja) | 2009-11-05 | 2015-09-30 | 国立研究開発法人理化学研究所 | 幹細胞の分化誘導方法 |
| KR102539240B1 (ko) * | 2014-01-23 | 2023-06-01 | 닛산 가가쿠 가부시키가이샤 | 배양 배지 조성물 |
| US11066660B2 (en) * | 2015-05-14 | 2021-07-20 | Public University Corporation Yokohama City University | Technique for aggregating macromolecules together with cells |
| WO2017160234A1 (en) * | 2016-03-14 | 2017-09-21 | Agency For Science, Technology And Research | Generation of midbrain-specific organoids from human pluripotent stem cells |
| EP3296018A1 (en) * | 2016-09-19 | 2018-03-21 | Ecole Polytechnique Fédérale de Lausanne (EPFL) | Organoid arrays |
| ES2903187T3 (es) * | 2017-06-13 | 2022-03-31 | Georg August Univ Goettingen Stiftung Oeffentlichen Rechts Univsmedizin | Procedimientos de producción de organoides neuronales de bioingeniería (BENO) y sus usos |
-
2020
- 2020-02-10 US US17/430,131 patent/US20220145247A1/en active Pending
- 2020-02-10 JP JP2021546212A patent/JP7541986B2/ja active Active
- 2020-02-10 CA CA3129656A patent/CA3129656A1/en active Pending
- 2020-02-10 WO PCT/EP2020/053237 patent/WO2020165059A1/en not_active Ceased
- 2020-02-10 EP EP20702840.8A patent/EP3924468A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004515236A (ja) | 2000-12-07 | 2004-05-27 | スリーエム イノベイティブ プロパティズ カンパニー | 自己拡散式微生物培養装置 |
| JP2016506244A (ja) | 2012-12-13 | 2016-03-03 | イーエムベーアー−インスティテュート フュール モレクラレ バイオテクロノジー ゲゼルシャフト ミットベシュレンクテル ハフツング | 三次元不均一分化組織培養 |
| JP2018506988A (ja) | 2015-03-03 | 2018-03-15 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 機能的ヒト組織の作製方法 |
Non-Patent Citations (6)
| Title |
|---|
| LANCATER A Madeline & KNOBLICH A Juergen，Generation of cerebral organoids from human pluripotent stem cells，NATURE PROTOCOLS，2014年09月04日，Vol.9, No.10，p.2329-2340 |
| LEE Wonjae & PARK Jon，3D patterned stem cell differentiation using thermo-responsive methylcellulose hydrogel molds，SCIENTIFIC REPORTS，Vol.6，p.1-11 |
| LI Xia et al.，A fully defined static suspension culture system for large-scale human embryonic stem cell production，Cell Death and Disease，2018年，Vol.9, No.892，p.1-9 |
| OTSUJI G. Tomomi et al.，A 3D Sphere Culture System Containing Functional Polymers for Large-Scale Human Pluripotent Stem Cell Production，Stem Cell Reports，2014年05月06日，Vol.2，p.734-745 |
| 小島 伸彦，ボトムアップ的手法による細胞集積型バイオマイクロデバイスの構築，科学研究費助成事業 研究報告書，2014年05月09日，p.1-5 |
| 鶴岡 茉佑子，第ＩＩＩ部 ライフサイエンスの研究開発に関連する主要トピック ８章 再生医療・幹細胞研究，ライフサイエンスフロンティア（科学技術に関する調査プロジェクト２０１５），2015年，p.191-202 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020165059A1 (en) | 2020-08-20 |
| CA3129656A1 (en) | 2020-08-20 |
| JP2022519376A (ja) | 2022-03-23 |
| US20220145247A1 (en) | 2022-05-12 |
| EP3924468A1 (en) | 2021-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7541986B2 (ja) | 三次元マトリックスなしでのヒト多能性幹細胞由来人工組織構造体の生成 | |
| Lindsay et al. | Bioprinting of stem cell expansion lattices | |
| CN107438669A (zh) | 用于治疗神经退行性疾病的干细胞衍生多巴胺能细胞的生产方法和组合物 | |
| TWI720333B (zh) | 多能性幹細胞的製備方法、使用該製備方法而製備出多能性幹細胞、改善劑、以及該多能性幹細胞之分化誘導方法 | |
| EP3196298B1 (en) | Method for inducing three-dimensional osteogenic differentiation of stem cells using hydrogel | |
| CN107267442A (zh) | 微载体上的多能干细胞培养 | |
| TW202024323A (zh) | 含有嗅神經細胞或其前驅細胞之細胞塊及其製造方法 | |
| AU2019273006B2 (en) | System for cell culture in a bioreactor | |
| WO2022168908A1 (ja) | 多能性幹細胞由来の陰窩－絨毛様構造を有する腸管細胞の製造方法及びその用途 | |
| JP2005531298A (ja) | 軟骨の欠損を修復するための再分化細胞 | |
| CN118302517A (zh) | 片状视网膜组织的制造方法 | |
| CN112852709B (zh) | 小鼠肺类器官培养方法 | |
| Zhang et al. | A high-throughput microfluidic platform for functional hiPSC-derived liver organoids with bile duct-and lobule-like structures | |
| CN118064350A (zh) | 一种构建子宫内膜类器官的试剂盒及其应用 | |
| Ferro et al. | Three-dimensional (3D) cell culture conditions, present and future improvements | |
| WO2005121319A1 (en) | Methods for production of mesodermal lineage cells | |
| Guan et al. | Tissue-specific extracellular matrix for the larger-scaled expansion of spinal cord organoids | |
| WO2025237735A1 (en) | Production of engineered skeletal muscle in a bioreactor | |
| JP7540434B2 (ja) | 温度応答性液状培地組成物 | |
| JP2025524999A (ja) | 分離ウェルマイクロプレートを使用する胚様体のヒドロゲルへの自動埋め込みの方法 | |
| WO2024204596A1 (ja) | 網膜組織の製造方法 | |
| Zanon | Establishment of an alginate based 3D culture system for the generation of dopaminergic neurons | |
| WO2022254961A1 (ja) | 幹細胞を作製するための細胞培養補助剤、及び幹細胞の作製方法 | |
| STEINDL | Advanced 3D hydrogel culture of human mesenchymal stem cells | |
| Vieira | Expansion of Human Induced Pluripotent Stem Cells on Dissolvable Microcarriers Under Dynamic Culture Conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230203 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230203 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240116 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240409 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240806 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240819 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7541986 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |